KR100849757B1 - 알레르겐에 대한 환자의 민감 상태를 선별하는 패치와그것의 용도 - Google Patents
알레르겐에 대한 환자의 민감 상태를 선별하는 패치와그것의 용도 Download PDFInfo
- Publication number
- KR100849757B1 KR100849757B1 KR1020037011739A KR20037011739A KR100849757B1 KR 100849757 B1 KR100849757 B1 KR 100849757B1 KR 1020037011739 A KR1020037011739 A KR 1020037011739A KR 20037011739 A KR20037011739 A KR 20037011739A KR 100849757 B1 KR100849757 B1 KR 100849757B1
- Authority
- KR
- South Korea
- Prior art keywords
- patch
- support
- allergen
- allergens
- adhesive
- Prior art date
Links
- 239000013566 allergen Substances 0.000 title claims description 125
- 238000012216 screening Methods 0.000 title description 7
- 230000035945 sensitivity Effects 0.000 title description 4
- 239000000853 adhesive Substances 0.000 claims abstract description 31
- 230000001070 adhesive effect Effects 0.000 claims abstract description 29
- 239000002245 particle Substances 0.000 claims abstract description 23
- 239000000463 material Substances 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims description 19
- 229920002678 cellulose Polymers 0.000 claims description 11
- 239000001913 cellulose Substances 0.000 claims description 11
- 239000011521 glass Substances 0.000 claims description 5
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 5
- 239000004033 plastic Substances 0.000 claims description 4
- 229920003023 plastic Polymers 0.000 claims description 4
- 239000011149 active material Substances 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 239000013256 coordination polymer Substances 0.000 claims description 2
- 239000004417 polycarbonate Substances 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- -1 polypropylene Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 229940088623 biologically active substance Drugs 0.000 abstract description 7
- 210000003491 skin Anatomy 0.000 description 31
- 238000012360 testing method Methods 0.000 description 28
- 206010020751 Hypersensitivity Diseases 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 230000007815 allergy Effects 0.000 description 10
- 231100000430 skin reaction Toxicity 0.000 description 9
- 206010040914 Skin reaction Diseases 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 230000004044 response Effects 0.000 description 8
- 230000035483 skin reaction Effects 0.000 description 8
- 210000004243 sweat Anatomy 0.000 description 7
- 241000283690 Bos taurus Species 0.000 description 6
- 208000026935 allergic disease Diseases 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 244000105624 Arachis hypogaea Species 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 239000013568 food allergen Substances 0.000 description 4
- 230000028709 inflammatory response Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 235000020232 peanut Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000000241 respiratory effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000004262 Food Hypersensitivity Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 102000014171 Milk Proteins Human genes 0.000 description 3
- 108010011756 Milk Proteins Proteins 0.000 description 3
- 230000000172 allergic effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 235000020932 food allergy Nutrition 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 241000238876 Acari Species 0.000 description 2
- 241000252254 Catostomidae Species 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010016946 Food allergy Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000000586 desensitisation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 206010024769 Local reaction Diseases 0.000 description 1
- 208000009793 Milk Hypersensitivity Diseases 0.000 description 1
- 201000010859 Milk allergy Diseases 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 208000028004 allergic respiratory disease Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 201000005299 metal allergy Diseases 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000012811 non-conductive material Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000013014 purified material Substances 0.000 description 1
- 201000004335 respiratory allergy Diseases 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0035—Vaccination diagnosis other than by injuring the skin, e.g. allergy test patches
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Abstract
Description
배터리 테스트를 기본으로 한 알레르기 진단용 수단은 가장 처음의 피부 테스트이다. 알레르겐과 접촉하는 피부 반응 양상은 홍반 형태(염증성 반응의 첫번째 임상 요소) 또는 국소 부종(염증성 반응의 다른 성분)의 존재로 나타내는 구진의 형태가 완화된 국소 염증성 피부 반응이 나타난다. 접촉 알레르겐이 아닌 다른 알레르겐의 피부 반응은 혈액내 면역 성분이 일정하게 순환하고 호흡 또는 소화 기관을 통해 몸으로 들어가서 피부하에 존재하는 알레르겐에 의해 림프구가 민감해지도록 하는 것에 의해 설명된다.
보다 바람직하게는 도포된 상기 알레르겐의 경우에, 본 발명에서 해결해야 할 첫번째 문제는 모든 알레르겐을 시험할 수 있으며, 또한 유기 알레르겐은 그것의 화학 반응 상태를 확실하게 유지할 수 있는 패치를 제공한다.
도 1은 본 발명의 바람직한 구체예의 도식적 대표도이다.
Claims (13)
- 정전기적 성질(electrostatic properties)을 갖는 지지체(support)의 형태로 되어 있으며, 상기 지지체의 둘레부(periphery)는 접착성 물질(adhesive material)로 코팅되어 있고, 지지체의 비-접착성 표면 중 일부 또는 전부는 입자 형태의 1 이상의 생물학적 활성 물질로 직접 피복되어 있으며, 상기 입자는 정전기력으로 인하여 지지체의 비-접착성 표면과의 접촉이 유지되는 것을 특징으로 하는 패치(patch).
- 제 1 항에 있어서,상기 지지체의 맞은 편에는 피부에 도포하기 전에 제거되기 위한 것으로 벗겨낼 수 있는 라벨을 가지는 것을 특징으로 하는 패치.
- 제 1 항에 있어서,상기 지지체는 셀룰로스 플라스틱(CA, CP), 폴리비닐 클로라이드(PVCs), 폴리프로필렌, 폴리스티렌, 폴리카보네이트 및 폴리아크릴을 포함하는 그룹으로부터 선택되는 중합체 또는 유리로 구성되는 것을 특징으로 하는 패치.
- 제 1 항에 있어서,상기 지지체의 뒷면은 벗겨낼 수 있는 라벨로 피복되어 있는 것을 특징으로 하는 패치.
- 제 1 항에 있어서,상기 지지체는 접착성 물질로 피복되지 않은 영역에 오목부위(hollow)를 형성하는 함몰부(depression)를 가지는 것을 특징으로 하는 패치.
- 제 1 항에 있어서,상기 활성 물질은 알레르겐(allergen) 형태인 것을 특징으로 하는 패치.
- 제 6 항에 있어서,상기 알레르겐은 동결건조, 저온살균 또는 이온화 처리가 된 것을 특징으로 하는 패치.
- 제 6 항 또는 제 7 항에 있어서,상기 알레르겐은 정제된 알레르겐 분획물의 형태인 것을 특징으로 하는 패치.
- 제 6 항에 있어서,지지체는 지지체 뒤면에 인쇄된 마크 형태, 패치를 제거할 때 피부 표면에 남아있는 임시 문신 형태, 또는 패치를 제거할 때 그것으로부터 분리되고 지지체의 접착 부분에 붙어있는 자가-접착 디스크(self-adhesive disk) 형태로 되어 있는 알레르겐 표시 장치(allergen marking device)를 가지는 것을 특징으로 하는 패치.
- 제 1 항에 있어서,접착 부위 또는 비-접착 부위에 pH의 국부 변화를 감지하는 컬러 표시기(colored indicator)를 갖는 것을 특징으로 하는 패치.
- 제 1 항에 있어서,상기 지지체는 각각 다른 알레르겐으로 피복된 정전기적 성질을 갖는 다수의 영역을 가지며, 각각의 정전기적 영역은 비-정전기적 영역에 의해 분리되는 것을 특징으로 하는 패치.
- 제 6 항에 의한 패치를 다수 포함하는 패치 키트(patch kit)로서,각각의 패치는 증가하는 알레르겐 양을 포함하는 것을 특징으로 하는 패치 키트.
- 삭제
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0103382A FR2822049B1 (fr) | 2001-03-13 | 2001-03-13 | Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation |
FR01/03382 | 2001-03-13 | ||
PCT/FR2002/000804 WO2002071950A1 (fr) | 2001-03-13 | 2002-03-06 | Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, et utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030082966A KR20030082966A (ko) | 2003-10-23 |
KR100849757B1 true KR100849757B1 (ko) | 2008-07-31 |
Family
ID=8861047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037011739A KR100849757B1 (ko) | 2001-03-13 | 2002-03-06 | 알레르겐에 대한 환자의 민감 상태를 선별하는 패치와그것의 용도 |
Country Status (15)
Country | Link |
---|---|
US (1) | US7722897B2 (ko) |
EP (1) | EP1367944B1 (ko) |
JP (1) | JP4177110B2 (ko) |
KR (1) | KR100849757B1 (ko) |
CN (1) | CN1243518C (ko) |
AT (1) | ATE279148T1 (ko) |
AU (1) | AU2002242807B2 (ko) |
CA (1) | CA2438325C (ko) |
DE (1) | DE60201582T2 (ko) |
DK (1) | DK1367944T3 (ko) |
EA (1) | EA005143B1 (ko) |
ES (1) | ES2229100T3 (ko) |
FR (1) | FR2822049B1 (ko) |
HK (1) | HK1065239A1 (ko) |
WO (1) | WO2002071950A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018030639A1 (ko) | 2016-08-12 | 2018-02-15 | 연세대학교 산학협력단 | 마이크로니들 패치, 이의 제조방법 및 이를 이용한 알레르기 질환 진단방법 |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7635488B2 (en) * | 2001-03-13 | 2009-12-22 | Dbv Technologies | Patches and uses thereof |
FR2822049B1 (fr) * | 2001-03-13 | 2003-08-01 | Dbv Medica 1 | Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation |
US20020194603A1 (en) * | 2001-06-15 | 2002-12-19 | Jay H. Connelly | Method and apparatus to distribute content using a multi-stage broadcast system |
GB0213437D0 (en) * | 2002-06-12 | 2002-07-24 | Univ Cranfield | Temporary tattoos: A novel vehicle for skin testing |
US6994870B2 (en) * | 2002-09-18 | 2006-02-07 | Jaw-Ji Tsai | Local nasal immunotherapy with allergen strip for allergic rhinitis |
FR2866553B1 (fr) * | 2004-02-19 | 2006-06-09 | Dbv Tech | Nouveau type de patch |
FR2870456A1 (fr) * | 2004-05-19 | 2005-11-25 | Dbv Technologies Sa | Test cutane mettant en oeuvre des proteines allergeniques partiellement hydrolysees |
BRPI0520264A2 (pt) * | 2005-05-31 | 2009-04-28 | Dbv Tech | adesivos dÉrmicos descartÁveis nço-invasivos e embalagem armazenadora para os mesmos |
US20070014728A1 (en) * | 2005-07-18 | 2007-01-18 | Imbert Delphine C | Device and method for increasing the throughput of irritation testing of transdermal formulations |
FR2921562B1 (fr) * | 2007-10-01 | 2012-06-15 | Dbv Tech | Dispositif adhesif pour application cutanee |
FR2924350B1 (fr) * | 2007-12-03 | 2010-08-13 | Dbv Tech | Procede et compositions pour la vaccination par voie cutanee |
FR2924349B1 (fr) * | 2007-12-03 | 2010-01-01 | Dbv Tech | Methode de desensibilitation aux allergenes |
FR2926466B1 (fr) * | 2008-01-23 | 2010-11-12 | Dbv Tech | Procede de fabrication de patchs par electrospray |
US8363259B2 (en) * | 2008-05-24 | 2013-01-29 | Activiews Ltd. | Method for producing printed patches for optical and high-contrast guidance |
ES2711927T3 (es) | 2009-03-13 | 2019-05-08 | Dbv Tech | Método para tratar el eccema |
CN107320722A (zh) | 2009-09-07 | 2017-11-07 | Dbv技术公司 | 治疗嗜酸细胞性食管炎的方法 |
CN107441483A (zh) | 2010-04-16 | 2017-12-08 | Dbv技术公司 | 免疫接种的方法 |
GB2490652A (en) * | 2011-04-18 | 2012-11-14 | Microtest Matrices Ltd | Methods of quantifying antibodies, especially IgE antibodies in a sample |
EP2726866A1 (en) * | 2011-06-29 | 2014-05-07 | Hds Limited | An improved micropatch for assessing chemical contact allergy |
EP2626082A1 (en) * | 2012-02-13 | 2013-08-14 | DBV Technologies | Method of preventing allergies |
CN103479400A (zh) * | 2012-06-11 | 2014-01-01 | 浙江我武生物科技股份有限公司 | 一种含有漆酚的皮炎诊断贴剂及其制备方法 |
CN103480005A (zh) * | 2012-06-11 | 2014-01-01 | 浙江我武生物科技股份有限公司 | 一种皮炎诊断贴剂及其制备方法 |
JP2016534083A (ja) | 2013-10-22 | 2016-11-04 | デベヴェ・テクノロジーズ | 血液因子に対する寛容を誘導することによって血友病を処置する方法 |
US20170007170A1 (en) | 2015-07-10 | 2017-01-12 | Rememdia LC | Allergy Skin Test Devices |
CN106377282A (zh) * | 2016-09-23 | 2017-02-08 | 何韶衡 | 一种用于斑贴试验的变应原膜及斑试器 |
CN110013558A (zh) * | 2016-09-23 | 2019-07-16 | 何韶衡 | 一种透明贴剂及其制备方法 |
US11318199B2 (en) | 2017-05-31 | 2022-05-03 | Texas Tech University System | Methods and devices for the treatment of food allergies |
WO2019160942A1 (en) * | 2018-02-13 | 2019-08-22 | Hamann Curt | Patches comprising urushiol, test panels comprising the same, and methods of using the same |
EP3820457A1 (en) | 2018-07-09 | 2021-05-19 | DBV Technologies | Optimized epicutaneous vaccination |
CN111603182A (zh) * | 2019-02-25 | 2020-09-01 | 上海添音生物科技有限公司 | 一种常见精神疾病辅助筛选皮肤测试反应器 |
EP3760194A1 (en) | 2019-07-01 | 2021-01-06 | DBV Technologies | Method of depositing a substance on a substrate |
AU2021327094A1 (en) * | 2020-08-18 | 2023-04-20 | All Skin Inc | Method and system for detecting skin contact reactions and making associated safe product recommendations |
US20230355737A1 (en) | 2020-09-28 | 2023-11-09 | Dbv Technologies | Particle comprising an rsv-f protein for use in rsv vaccination |
IT202000030071A1 (it) * | 2020-12-15 | 2021-03-15 | Service Biotech S R L | Realizzazione di un dispositivo di segnalazione dermatologico simile ad un patch test per l’identificazione di reazione allergica di medicamenti, preventiva alla somministrazione al paziente. |
EP4370145A1 (en) | 2021-07-16 | 2024-05-22 | DBV Technologies | Immunotherapeutic method for increasing cashew tolerance in a subject |
CA3236825A1 (en) * | 2021-11-01 | 2023-05-04 | All Skin Inc | Prefilled cutaneous patch with landmark |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB501873A (en) | 1937-04-20 | 1939-03-07 | Hermann Vollmer | New or improved means for carrying out medical tests |
BE642548A (ko) | 1963-01-19 | 1964-05-14 | ||
SE337223B (ko) * | 1967-05-23 | 1971-08-02 | Pharmacia Ab | |
US3837340A (en) * | 1971-10-20 | 1974-09-24 | Lilly Co Eli | Device for administering immunication against virus |
US3894531A (en) * | 1974-04-12 | 1975-07-15 | Jr Milton A Saunders | Skin patch test device with peelable label |
US4450844A (en) * | 1981-11-23 | 1984-05-29 | Hill Top Research, Inc. | Patch system for use on the skin |
US4435180A (en) | 1982-05-25 | 1984-03-06 | Alza Corporation | Elastomeric active agent delivery system and method of use |
AU590711B2 (en) | 1982-10-13 | 1989-11-16 | Biowhittaker, Inc. | Stable allergenic extracts and methods |
SE8404895L (sv) | 1984-10-01 | 1986-03-17 | Torkel Ingemar Fischer | Medel for en overkenslighetstest |
US4743249A (en) * | 1986-02-14 | 1988-05-10 | Ciba-Geigy Corp. | Dermal and transdermal patches having a discontinuous pattern adhesive layer |
US4788971A (en) * | 1987-07-13 | 1988-12-06 | Hill Top Research, Inc. | Patch system for use on the skin |
US4821733A (en) * | 1987-08-18 | 1989-04-18 | Dermal Systems International | Transdermal detection system |
US5438984A (en) * | 1988-09-08 | 1995-08-08 | Sudor Partners | Apparatus and method for the collection of analytes on a dermal patch |
US5037587A (en) | 1989-07-17 | 1991-08-06 | Mitsui Toatsu Chemicals, Inc. | Preparation process of polyimide film |
US5236455A (en) * | 1992-02-10 | 1993-08-17 | Wilk Peter J | Tympanic patch, applicator, and related method |
JPH06238008A (ja) | 1993-02-15 | 1994-08-30 | Yuutoku Yakuhin Kogyo Kk | パッチテスト用具 |
AU5543196A (en) * | 1995-04-12 | 1996-10-30 | Robert B. Hopp | Skin patch for use in contact immunotherapy |
US6093419A (en) * | 1995-06-07 | 2000-07-25 | Lectec Corporation | Compliance verification method and device in compulsory drug administration |
US5827530A (en) | 1996-02-05 | 1998-10-27 | Reed, Jr.; Fred Dewitt | Fillable patch for dermal or transdermal delivery |
US5827608A (en) * | 1996-10-28 | 1998-10-27 | Minnesota Mining And Manufacturing Company | Method of forming a thermoplastic layer on a flexible two-dimensional substrate and powder for preparing same |
US20060002949A1 (en) * | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
DE29621365U1 (de) * | 1996-12-11 | 1997-02-27 | Lohmann Gmbh & Co Kg, 56567 Neuwied | Epikutan-Testpflaster |
US6210705B1 (en) * | 1997-12-15 | 2001-04-03 | Noven Pharmaceuticals, Nc. | Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
US20020102291A1 (en) * | 1997-12-15 | 2002-08-01 | Noven Pharmaceuticals, Inc. | Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
FR2781670B1 (fr) | 1998-07-30 | 2001-09-07 | Oreal | Patch cosmetique ou pharmaceutique et son conditionnement |
JP2987702B1 (ja) | 1998-09-07 | 1999-12-06 | 岩手新浄農業協同組合 | 粉末青果物の製造方法 |
US6159497A (en) | 1998-10-30 | 2000-12-12 | Noven Pharmaceuticals, Inc. | Patch applicator |
JP2002535293A (ja) | 1999-01-22 | 2002-10-22 | パウダージェクト リサーチ リミテッド | 無針の経皮的粉末薬物送達を増強する方法 |
SI1031346T1 (en) | 1999-01-27 | 2002-08-31 | Idea Ag | Noninvasive vaccination through the skin |
AU2001231154A1 (en) * | 2000-01-24 | 2001-07-31 | Adherex Technologies Inc. | Peptidomimetic modulators of cell adhesion |
AU2001288628A1 (en) * | 2000-08-31 | 2002-03-13 | Loyola University Chicago | Method and reagents for treatment of skin disorders by modulating the notch pathway |
ATE298528T1 (de) | 2000-10-13 | 2005-07-15 | Alza Corp | Mikroklingeanordungsaufprallapplikator |
FR2822049B1 (fr) * | 2001-03-13 | 2003-08-01 | Dbv Medica 1 | Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation |
US7635488B2 (en) * | 2001-03-13 | 2009-12-22 | Dbv Technologies | Patches and uses thereof |
WO2002074325A1 (en) | 2001-03-19 | 2002-09-26 | Iomai Corporation | Patch for transcutaneous immunization |
US20050074462A1 (en) | 2001-05-23 | 2005-04-07 | Duotol Ab | Supression of allergic reactions by transdermal administration of allergens conjugated to cholera toxin or fragments thereof |
CN1578647B (zh) * | 2001-08-29 | 2010-04-07 | 里卡多·A·P·德卡瓦尔霍 | 一种用于单向传送药剂到目标组织的可以手术植入的及可密封的装置 |
US20040137004A1 (en) * | 2002-03-19 | 2004-07-15 | Glenn Gregory M | Patch for transcutaneous immunization |
US20060147509A1 (en) * | 2002-10-02 | 2006-07-06 | Kirkby Nikolai S | Composition for vaccination |
JP2006503072A (ja) | 2002-10-02 | 2006-01-26 | ノルディック ワクチン テクノロジー アクティーゼルスカブ | ワクチン接種用組成物 |
US20040111071A1 (en) | 2002-12-09 | 2004-06-10 | Jeffrey Lewis Powers | Portable device for dispensing hand treatments |
-
2001
- 2001-03-13 FR FR0103382A patent/FR2822049B1/fr not_active Expired - Fee Related
-
2002
- 2002-03-06 CN CNB028063236A patent/CN1243518C/zh not_active Expired - Lifetime
- 2002-03-06 EP EP02708443A patent/EP1367944B1/fr not_active Expired - Lifetime
- 2002-03-06 DE DE60201582T patent/DE60201582T2/de not_active Expired - Lifetime
- 2002-03-06 ES ES02708443T patent/ES2229100T3/es not_active Expired - Lifetime
- 2002-03-06 DK DK02708443T patent/DK1367944T3/da active
- 2002-03-06 CA CA2438325A patent/CA2438325C/fr not_active Expired - Lifetime
- 2002-03-06 AU AU2002242807A patent/AU2002242807B2/en not_active Expired
- 2002-03-06 JP JP2002570912A patent/JP4177110B2/ja not_active Expired - Lifetime
- 2002-03-06 EA EA200301003A patent/EA005143B1/ru not_active IP Right Cessation
- 2002-03-06 AT AT02708443T patent/ATE279148T1/de not_active IP Right Cessation
- 2002-03-06 WO PCT/FR2002/000804 patent/WO2002071950A1/fr active IP Right Grant
- 2002-03-06 KR KR1020037011739A patent/KR100849757B1/ko active IP Right Grant
-
2003
- 2003-09-10 US US10/659,566 patent/US7722897B2/en active Active
-
2004
- 2004-10-18 HK HK04108123A patent/HK1065239A1/xx not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018030639A1 (ko) | 2016-08-12 | 2018-02-15 | 연세대학교 산학협력단 | 마이크로니들 패치, 이의 제조방법 및 이를 이용한 알레르기 질환 진단방법 |
Also Published As
Publication number | Publication date |
---|---|
US20040047902A1 (en) | 2004-03-11 |
ATE279148T1 (de) | 2004-10-15 |
ES2229100T3 (es) | 2005-04-16 |
CA2438325A1 (fr) | 2002-09-19 |
DE60201582D1 (de) | 2004-11-18 |
FR2822049B1 (fr) | 2003-08-01 |
HK1065239A1 (en) | 2005-02-18 |
EP1367944B1 (fr) | 2004-10-13 |
EP1367944A1 (fr) | 2003-12-10 |
CN1496239A (zh) | 2004-05-12 |
DK1367944T3 (da) | 2004-11-22 |
EA200301003A1 (ru) | 2004-02-26 |
AU2002242807B2 (en) | 2004-09-16 |
WO2002071950A1 (fr) | 2002-09-19 |
FR2822049A1 (fr) | 2002-09-20 |
KR20030082966A (ko) | 2003-10-23 |
CN1243518C (zh) | 2006-03-01 |
JP2004527290A (ja) | 2004-09-09 |
EA005143B1 (ru) | 2004-12-30 |
JP4177110B2 (ja) | 2008-11-05 |
CA2438325C (fr) | 2011-02-08 |
DE60201582T2 (de) | 2005-02-17 |
US7722897B2 (en) | 2010-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100849757B1 (ko) | 알레르겐에 대한 환자의 민감 상태를 선별하는 패치와그것의 용도 | |
JP5243408B2 (ja) | パッチおよびその使用 | |
US6071247A (en) | Skin blister biopsy apparatus and method | |
EP3498175A1 (en) | Microneedle patch, manufacturing method therefor, and allergic disease diagnosis method using same | |
WO2008139324A2 (en) | Fluid sample collection device | |
JP5033195B2 (ja) | アレルゲンの効力を測定するための標準化血清混合物の調製方法およびその使用 | |
JP2003344394A (ja) | 皮膚反応試験パッチとその試験方法 | |
DE19715747C2 (de) | Verfahren und Vorrichtung zur Ermittlung des Klebeverhaltens von haftklebenden Flächengebilden auf der Haut von Mensch oder Säugetier | |
Mørtz et al. | Skin tests for immediate hypersensitivity | |
EP0172822B1 (en) | Method for analysis of the activity of receptors of certain cells | |
JP2004065675A (ja) | 皮膚反応試験方法とそれに用いる試験部材 | |
EP0327629A1 (de) | Verfahren und vorrichtung zur untersuchung von vollblut, anderen körperflüssigkeiten und sonstigen biologischen flüssigkeiten | |
Van Wye et al. | 846 Tick-bite anaphylaxis: A case report in America wtth in vitro evidence of IgE-mediated hypersensitivity | |
Hermann et al. | 847 Renin angiotensin system in hymenoptera venom allergy | |
Braybrook | Talking Point. Is it as simple as ABC?—a biocompatibility consensus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0105 | International application |
Patent event date: 20030908 Patent event code: PA01051R01D Comment text: International Patent Application |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20070119 Comment text: Request for Examination of Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20071126 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20080522 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20080725 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20080724 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20110725 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20120712 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20130711 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20130711 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140710 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20140710 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20150714 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20150714 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170710 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20170710 Start annual number: 10 End annual number: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180711 Year of fee payment: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20180711 Start annual number: 11 End annual number: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20200708 Start annual number: 13 End annual number: 13 |
|
PR1001 | Payment of annual fee |
Payment date: 20210707 Start annual number: 14 End annual number: 14 |
|
PC1801 | Expiration of term |
Termination date: 20220906 Termination category: Expiration of duration |